Legal

From ghost patients and fake genetic tests to DME laundering rings and opioid pill mills, the DOJ’s 2025 health care fraud crackdown paints a sobering picture of a system under attack — and a federal response gaining traction.

As workplace violence rises, health care facilities must shift from retrofitted tech to frontline-first safety solutions

Compare the potential strategic options for transactions with hospitals, private equity platforms and other health care companies

Explore the essentials of forming a medical practice partnership, including operating agreements, income distribution, and buy-in/buy-out strategies before signing a contract.

Medical malpractice insurance needs an update

A 10-step guide for physicians to assess their compensation accurately, using benchmarks and data to ensure they receive fair pay for their expertise.

As use of artificial intelligence grows rapidly in health care, the American Medical Association brought together an expert panel to highlight policy changes, transparency concerns and implications for physician practices.

New physicians need to learn essential financial habits to manage student debt, budget wisely, and start retirement savings early for a secure future.

A recent district court case shows an LLC might not be enough

The first Practice Academy event of 2025 featured educational sessions on practice leadership, medical malpractice and audit-proof coding.

Study warns that artificial intelligence could increase legal risk and burnout if health systems fail to support doctors.

What’s fueling salary increases for primary care physicians? Talent shortages, increased burnout and rising administrative burdens — not greed.

Occurrence, claims-made and tail insurance explained.

Physicians plan for patients’ futures. It’s time to plan for their own with digital estate debt tools.

GLP-1s are in high demand from patients, and the results are often impressive. But are there hidden risks in prescribing these drugs?

GLP-1s are in high demand from patients, and the results are often impressive. But are there hidden risks in prescribing these drugs?

GLP-1s are in high demand from patients, and the results are often impressive. But are there hidden risks in prescribing these drugs?

GLP-1s are in high demand from patients, and the results are often impressive. But are there hidden risks in prescribing these drugs?

GLP-1s are in high demand from patients, and the results are often impressive. But are there hidden risks in prescribing these drugs?

GLP-1s are in high demand from patients, and the results are often impressive. But are there hidden risks in prescribing these drugs?

GLP-1s are in high demand from patients, and the results are often impressive. But are there hidden risks in prescribing these drugs?

GLP-1s are in high demand from patients, and the results are often impressive. But are there hidden risks in prescribing these drugs?

GLP-1s are in high demand from patients, and the results are often impressive. But are there hidden risks in prescribing these drugs?

GLP-1s are in high demand from patients, and the results are often impressive. But are there hidden risks in prescribing these drugs?

How to safeguard the benefits of private practice.

Tariffs will likely result in rising costs and supply chain disruptions that will reshape the economic outlook for the global economy — and your business too.

The time is now to create an action plan that fits your practice when it comes to cutting costs and raising revenue streams. Read Medical Economics Insider to get started.

In many states, nurse practitioners are gaining greater permission to practice and prescribe independently, with varying levels of physician oversight. What do physicians think of this trend? See our exclusive physician survey results to find out.

Introducing the inaugural issue of Medical Economics Insider, featuring practical tips and expert interviews on medical practice finance, plus exclusive survey data on how physicians feel about nurse practitioner independence.

Andrea Greco, SVP of health care safety at CENTEGIX, sat down with Medical Economics for an exclusive Q&A.